Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 4:15 PM View:  | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 26-Sep-24 | Planned Option Sale | 2,542 | $49.03 | $124,634.00 | (11%) 22.7K to 20.16K | |
| 30-Sep-24 4:15 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 26-Sep-24 | Option Exercise | 7,473 | -- | -- | 49% 15.23K to 22.7K | |
| 13-Aug-24 4:12 PM View: | Smith Cynthia Director | Agios Pharmaceuticals, Inc. (AGIO) | 11-Aug-24 | Option Exercise | 2,302 | -- | -- | 40% 5.69K to 7.99K | |
| 12-Aug-24 5:15 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 08-Aug-24 | Planned Option Sale | 11,091 | $42.75 | $474,140.00 | (12%) 89.88K to 78.79K | |
| 12-Aug-24 5:15 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 08-Aug-24 | Option Exercise | 22,691 | -- | -- | 34% 67.19K to 89.88K | |
| 17-Jun-24 5:13 PM View: | Capello Jeffrey D Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 1,976 | -- | -- | 100% 0 to 1.98K | |
| 17-Jun-24 5:29 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | < 1% 472.71K to 476.1K | |
| 17-Jun-24 5:19 PM View: | Ho Maykin Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 29% 11.52K to 14.91K | |
| 17-Jun-24 5:20 PM View: | Smith Cynthia Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 147% 2.3K to 5.69K | |
| 17-Jun-24 5:15 PM View: | Owen Catherine E. Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 1,976 | -- | -- | 100% 0 to 1.98K | |
| 17-Jun-24 5:32 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Gift | 3,564 | -- | -- | (32%) 11.11K to 7.55K | |
| 17-Jun-24 5:18 PM View: | Scadden David Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 28% 12.1K to 15.48K | |
| 17-Jun-24 5:22 PM View: | Ballal Rahul D. Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 147% 2.3K to 5.69K | |
| 17-Jun-24 5:31 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 2% 137.4K to 140.78K | |
| 17-Jun-24 5:32 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 44% 7.72K to 11.11K | |
| 07-Jun-24 4:25 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jun-24 | Option Exercise | 25,527 | -- | -- | 47% 53.78K to 79.31K | |
| 07-Jun-24 4:25 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jun-24 | Planned Option Sale | 12,115 | $48.84 | $591,697.00 | (15%) 79.31K to 67.19K | |
| 05-Jun-24 4:14 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 03-Jun-24 | Market Sale | 1,362 | $44.39 | $60,459.20 | (47%) 2.89K to 1.52K | (5%) |
| 10-Apr-24 4:03 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 10-Apr-24 | Planned Option Sale | 7,791 | $27.55 | $214,642.00 | (5%) 145.19K to 137.4K | |
| 10-Apr-24 4:03 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 08-Apr-24 | Option Exercise | 15,934 | -- | -- | 12% 129.25K to 145.19K | |
| 11-Mar-24 4:09 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 07-Mar-24 | Sale | 1,285 | $31.62 | $40,631.70 | (14%) 9.01K to 7.72K | |
| 07-Mar-24 6:49 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 06-Mar-24 | Sale | 4,415 | $31.99 | $141,236.00 | (33%) 13.42K to 9.01K | |
| 07-Mar-24 6:47 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Sale | 1,913 | $31.75 | $60,737.80 | (40%) 4.8K to 2.89K | |
| 05-Mar-24 4:08 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 2,642 | $32.57 | $86,049.90 | (7%) 39.81K to 37.17K | |
| 05-Mar-24 4:20 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 2,642 | $32.57 | $86,049.90 | (6%) 41.71K to 39.07K | |
| 07-Mar-24 6:49 PM View: | Foster-Cheek Kaye I Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Sale | 300 | $32.21 | $9,663.00 | (2%) 13.72K to 13.42K | |
| 05-Mar-24 4:18 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 672 | $32.57 | $21,887.00 | (4%) 15.51K to 14.84K | |
| 05-Mar-24 4:15 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 1,214 | $32.57 | $39,540.00 | (20%) 6.01K to 4.8K | |
| 05-Mar-24 4:10 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 4,156 | $32.57 | $135,361.00 | (7%) 57.94K to 53.78K | |
| 05-Mar-24 4:15 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 3,127 | -- | -- | 121% 2.59K to 5.72K | |
| 05-Mar-24 4:08 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 7,834 | -- | -- | 26% 30.68K to 38.52K | |
| 05-Mar-24 4:10 PM View: | Goff Brian Chief Executive Officer Director | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 8,500 | -- | -- | 17% 49.44K to 57.94K | |
| 05-Mar-24 4:18 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 2,000 | -- | -- | 15% 13.51K to 15.51K | |
| 05-Mar-24 4:20 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 7,834 | -- | -- | 24% 32.58K to 40.41K | |
| 29-Feb-24 4:05 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Exercise | 69,329 | $31.64 | $2,193,570.00 | 15% 472.71K to 542.04K | |
| 29-Feb-24 4:05 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Sale | 69,329 | $34.67 | $2,403,590.00 | (13%) 542.04K to 472.71K | |
| 27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Exercise | 20,411 | $31.64 | $645,804.00 | 4% 472.71K to 493.12K | |
| 27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Sale | 20,411 | $33.19 | $677,441.00 | (4%) 493.12K to 472.71K | |
| 27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Exercise | 47,731 | $31.64 | $1,510,210.00 | 10% 472.71K to 520.44K | |
| 27-Feb-24 4:04 PM View: | Schenkein David P Director | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Sale | 47,731 | $33.05 | $1,577,510.00 | (9%) 520.44K to 472.71K | |
| 22-Feb-24 5:43 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 20-Feb-24 | Sale | 504 | $26.63 | $13,421.50 | (16%) 3.25K to 2.74K | |
| 14-Feb-24 5:53 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 642 | $25.14 | $16,139.90 | (2%) 34.07K to 33.43K | |
| 14-Feb-24 5:51 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 545 | $25.14 | $13,701.30 | (2%) 32.21K to 31.67K | |
| 14-Feb-24 5:50 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-24 | Planned Option Sale | 273 | $25.14 | $6,863.22 | (8%) 3.52K to 3.25K | |
| 14-Feb-24 5:50 PM View: | Washburn Theodore James Jr. Principal Accounting Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 777 | -- | -- | 28% 2.74K to 3.52K | |
| 14-Feb-24 5:51 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 1,833 | -- | -- | 6% 30.38K to 32.21K | |
| 14-Feb-24 5:53 PM View: | Gheuens Sarah Chief Medical Officer | Agios Pharmaceuticals, Inc. (AGIO) | 12-Feb-24 | Option Exercise | 2,162 | -- | -- | 7% 31.91K to 34.07K | |
| 24-Jan-24 4:22 PM View: | Fouse Jacqualyn A Director | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 10,722 | $21.64 | $232,024.00 | (8%) 139.97K to 129.25K | |
| 24-Jan-24 4:23 PM View: | Jones Cecilia Chief Financial Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,886 | $21.64 | $40,813.00 | (13%) 14.96K to 13.07K | |
| 24-Jan-24 4:25 PM View: | Burns James William Chief Legal Officer | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 1,708 | $21.64 | $36,961.10 | (5%) 32.09K to 30.38K |
